Achillion Pharma (ACHN) Reports 4.8 Log10 Reduction With ACH-3422
Tweet Send to a Friend
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced positive interim results from two studies supporting a short duration, potentially best-in-disease regimen ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE